Who we are


No Patient Left Behind is a non-profit dedicated to making drugs affordable for every American. The organization is both designing and advocating for healthcare reforms that would lower or end copays and other out-of-pocket costs today while encouraging the innovation that gives all of us hope for tomorrow.

Our team

No Patient Left Behind was founded in 2020 by a group of patients, patient advocates, physicians, scientists, policymakers, industry leaders, and biotech investors.
Lynda Gorov
Lynda Gorov
NPLB team member
Executive Editor, No Patient Left Behind
Peter Rubin
Peter Rubin
NPLB team member
Executive Director, No Patient Left Behind
Keith Murphy
Keith Murphy
Co-chair, Advisory board
CEO and Founder, Viscient Biosciences
Sara Nayeem
Sara Nayeem
Co-chair, Advisory board
Partner, Avoro Ventures
DA Wallach
DA Wallach
Board member
Venture Capital Investor and Recording Artist
David Beier
David Beier
Board member
Globally recognized leader in healthcare policy and pricing
Gunnar Esiason
Gunnar Esiason
Board member
Director of Patient Outreach, Boomer Esiason Foundation
Heidi Wagner
Heidi Wagner
Board member
Jessica Sagers
Jessica Sagers
Steering committee
Head of Engagement, RA Capital Management
Jim Greenwood
Jim Greenwood
Steering committee
Former President and CEO, Biotechnology Industry Organization
Patricia Fraser
Patricia Fraser
Board member
Safety Physician, Sanofi Genzyme, Rheumatologist, Brigham and Women's
Peter Kolchinsky
Peter Kolchinsky
Steering committee
Founder of NPLB. Founder and Managing Director, RA Capital Management

Our supporters

We’re building support across
the industry

Life Science Builders agree that society's payments for branded drugs must be a finite mortgage, oppose the rent extraction that is on the rise in the drug industry today, and stand with us in calling on Congress to pass Contractual Genericization.

Read more